Literature DB >> 7871740

Distinctive kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments.

M Sangster1, L Hyland, R Sealy, C Coleclough.   

Abstract

The single-cell ELISPOT assay was used to determine the frequency and isotype commitment of virus-specific antibody-forming cells (AFC) at different anatomical locations following intranasal Sendai virus infection of C57BL/6 and 129/Sv mice. AFC responses in the mediastinal and cervical lymph nodes showed sharp increases and declines, first of IgM AFC, peaking about 7 days after infection, and then of IgG and IgA AFC, peaking about 10 days after infection. A wave of IgM AFC preceding the other isotypes was less evident in the spleen, where peak frequencies of AFC occurred 14 days after infection. Virus-specific AFC appeared in the bone marrow with a unique kinetic pattern, increasing in frequency gradually over the first 3 weeks after infection to a plateau that remained constant. Circulating IgM and IgG achieved significant titers approximately a week after infection; IgM titers were transient, but IgG levels increased sharply and remained high, reflecting the longevity of the bone marrow AFC response. Strain differences in isotype bias were noted, particularly preferential switching to the gamma 2a gene in 129/Sv mice. The B-cell response to acute respiratory viral infection thus exhibits features that are distinct from the primary response to nonreplicating antigens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7871740     DOI: 10.1006/viro.1995.1079

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens.

Authors:  Robert Sealy; Sherri Surman; Julia L Hurwitz; Christopher Coleclough
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

2.  Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection.

Authors:  Daisy J Vanitha; Hye Mee Joo; Barry T Rouse; Mark Y Sangster
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

3.  The cytotoxic T-lymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon.

Authors:  X Y Mo; R A Tripp; M Y Sangster; P C Doherty
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Modification of the Sendai virus-specific antibody and CD8+ T-cell responses in mice homozygous for disruption of the interleukin-4 gene.

Authors:  X Y Mo; M Y Sangster; R A Tripp; P C Doherty
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein.

Authors:  C M Boyle; M Morin; R G Webster; H L Robinson
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients.

Authors:  A Sicard; T W Phares; H Yu; R Fan; W M Baldwin; R L Fairchild; A Valujskikh
Journal:  Am J Transplant       Date:  2012-03-15       Impact factor: 8.086

7.  Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study.

Authors:  Crystal W Burke; Mei Li; Julia L Hurwitz; Peter Vogel; Charles J Russell
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

8.  Quantitation of acute phase proteins and protein electrophoresis in monitoring the acute inflammatory process in experimentally and naturally infected mice.

Authors:  Carolyn Cray; David G Besselsen; Jody L Hart; David Yoon; Marilyn Rodriguez; Julia Zaias; Norman H Altman
Journal:  Comp Med       Date:  2010-08       Impact factor: 0.982

9.  Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium.

Authors:  D J Topham; R A Tripp; S R Sarawar; M Y Sangster; P C Doherty
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors:  Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2009-02-04       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.